Joseph D’agostino Sells 30,000 Shares of Milestone Scientific Inc. (NYSEAMERICAN:MLSS) Stock

Milestone Scientific Inc. (NYSEAMERICAN:MLSS) CFO Joseph D’agostino sold 30,000 shares of the company’s stock in a transaction on Tuesday, December 29th. The shares were sold at an average price of $1.97, for a total value of $59,100.00. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Joseph D’agostino also recently made the following trade(s):

  • On Wednesday, December 16th, Joseph D’agostino sold 40,000 shares of Milestone Scientific stock. The stock was sold at an average price of $1.96, for a total value of $78,400.00.
  • On Wednesday, December 9th, Joseph D’agostino sold 10,000 shares of Milestone Scientific stock. The stock was sold at an average price of $1.88, for a total value of $18,800.00.
  • On Monday, December 7th, Joseph D’agostino sold 10,000 shares of Milestone Scientific stock. The stock was sold at an average price of $1.85, for a total value of $18,500.00.
  • On Monday, November 30th, Joseph D’agostino sold 31,000 shares of Milestone Scientific stock. The stock was sold at an average price of $1.65, for a total value of $51,150.00.

Shares of NYSEAMERICAN:MLSS opened at $2.12 on Friday. Milestone Scientific Inc. has a twelve month low of $0.85 and a twelve month high of $3.05.

Milestone Scientific (NYSEAMERICAN:MLSS) last announced its earnings results on Tuesday, November 17th. The medical instruments supplier reported ($0.02) earnings per share for the quarter, beating the consensus estimate of ($0.05) by $0.03. The business had revenue of $1.25 million for the quarter, compared to the consensus estimate of $1.00 million.

Large investors have recently made changes to their positions in the stock. Squarepoint Ops LLC acquired a new position in shares of Milestone Scientific in the 3rd quarter worth approximately $187,000. Bridgeway Capital Management Inc. raised its holdings in shares of Milestone Scientific by 72.3% in the 2nd quarter. Bridgeway Capital Management Inc. now owns 237,800 shares of the medical instruments supplier’s stock worth $464,000 after buying an additional 99,800 shares in the last quarter. Nuveen Asset Management LLC acquired a new position in shares of Milestone Scientific in the 2nd quarter worth approximately $332,000. Charles Schwab Investment Management Inc. acquired a new position in shares of Milestone Scientific in the 2nd quarter worth approximately $190,000. Finally, Jane Street Group LLC acquired a new position in shares of Milestone Scientific in the 2nd quarter worth approximately $118,000.

Separately, Northland Securities initiated coverage on Milestone Scientific in a research note on Wednesday, September 16th. They set a “market perform” rating for the company.

Milestone Scientific Company Profile

Milestone Scientific, Inc develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent System that are used to control the flow rate of the anesthesia during the injection, which allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns.

Further Reading: How are capital gains distributions different for tax-deferred account?

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.